Microplastics have been found almost everywhere that scientists have looked for them. Now these bits of plastic -- from 1 to 62 micrometers long -- have been found in the filtered solutions used for ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

Preliminary data readouts for less-frequent intravenous dosing of nemvaleukin alfa in the ARTISTRY-6 trial in patients with cutaneous melanoma expected in 1H 2025 for monotherapy (cohort 3) and 2H ...

Microplastics have been found almost everywhere that scientists have looked for them. Now, according to research published in Environment & Health, these bits of plastic—from 1 to 62 micrometers ...

The Government of Alberta has made Pluvicto, a new radiopharmaceutical treatment for advanced prostate cancer, available to Albertans in an effort to improve treatment access.

Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.